Senso Medical Labs designs and develops OEM platforms for multichannel wearables capable of sensing biopotential signals (e.g. EMG/EEG) as well as electrochemical signals that involve accurate, very low leakage current-sensing preamps. The company has developed BIOPOT2, a platform for 16 channels of biopotential monitoring specifically targeted toward EEG/EMG recordings. The ultra-low-power platform allows for 8 to 16 channels of biopotential monitoring and supports the latest Bluetooth standard (BLE5.0). Senso Medicals wireless platform is able to conduct event-related EEG acquisition in addition to a wireless proprietary mode that can enable more than 2 Mbps over an ultra-low-power 2.4 GHz RF link.